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Spinal cord injury (SCI) results in sensory and motor dysfunction and ultimately physical, psychological, 
and financial burden.  Unfortunately, the cure for SCI remains elusive and intensive neurorehabilitation 
produces only modest functional gains.  The most abundant cells in the CNS, astrocytes, are essential to 
neuronal function through bidirectional communication, support, and maintenance of the blood-brain / 
blood-spinal cord barrier (BBB/BSCB).  Studies of the injury epicenter have identified activation and 
proliferation of astrocytes in the production of a glial scar as an essential component of the innate post-
injury response.  While this response is well characterized, the role of astrocytes in remote regions is 
controversial and less understood.  Studies suggest a decreasing gradient of astrocyte reactivity moving 
away from the epicenter, however studies extending into the lumbar cord display conflicting results.  To 
determine the remote astrocytic response, we examined the time course of astrocyte dysfunction in the 
intermediate grey matter of the lumbar spinal cord at 7, 14, 21, and 42 days post injury (dpi) using 
C56BL/6 mice after a moderate (75 kilodyne) midthoracic contusion injury.  We examined the BSCB in 
detail by labeling vasculature with tomato lectin, astrocytes with GFAP, and their interface with 
aquaporin-4.  Additionally, we used the cell adhesion molecule, ICAM-1, to determine the presence of 
active trafficking of peripheral cells into the CNS as well as Iba-1 to examine microglia/macrophage 
morphology.  GFAP was seen to be significantly upregulated at 7 dpi and remained slightly elevated 
through 42 dpi.  Microglia/macrophages displayed a reactive phenotype and increased expression through 
42 dpi with biphasic peaks at 7 and 21 dpi.  ICAM-1 showed slight increases at 14 dpi, indicating active 
trafficking of peripheral immune cells into the cord, and AQP4 was localized to the vasculature at all time 
points with an apparent increase in co-labeling at 7 dpi.  These results provide valuable insight into 
astrocyte dysfunction in key locomotor regions essential for functional recovery following SCI as well as 




 In the United States alone, there are an 
estimated 276,000 people living with spinal cord 
injuries (SCI) and 12,500 new cases yearly 
(NSCISC).  The physical and emotional toll that 
an SCI exacts on an individual is extreme not 
only for those affected, but their family and 
friends as well.  While pharmacological 
interventions as well as activity-based therapies 
have been extensively studied for years, 
interventions capable of returning patients to 
their pre-injury normal function remain elusive.  
This may be due in part to the complex nature of 
SCI and the many areas that remain poorly 
understood.  While the injury response has been 
well characterized at the epicenter, it is important 
to understand the remote microenvironment 
caudal to the lesion, where locomotor central 
pattern generators (CPGs) are located (Kiarulff, 




 Of increasing interest to our lab is the 
response of astrocytes in areas associated with 
locomotor functioning, since this remains 
unknown.  The intermediate grey matter of the 
lumbar spinal cord contains CPGs, which are 
involved in producing rhythmic outputs at the 
level of the cord.  CPGs have been localized 
partially to lamina VII of the lumbar cord by 
investigations of c-fos positive cells.  This study 
found a great number of c-fos positive cells in 
lamina VII (Ahn et al., 2006).  Lesion studies 
have also shown localization of CPG networks to 
the intermediate grey matter of the lumbar spinal 
cord (Kjaerulff, 1996).  Behavioral treatments 
like treadmill- training target CPGs.  This makes 
the intermediate zone an important area to focus 
on to reduce this secondary inflammatory 







 Astrocytes are among the most abundant 
cells in the CNS.  Astrocytes are essential to 
formation and maintenance of the blood brain 
barrier (BBB) / blood spinal cord barrier 
(BSCB).  They are also involved in regulation of 
blood flow through their numerous contacts with 
blood vessels, homeostasis of fluid and ions, 
BBB barrier properties, and a variety of other 
functions (Sofroniew and Vinters, 2010).  The 
role of astrocytes following SCI remains 
controversial.  Some researchers suggest that 
therapeutic removal of reactive astrocytes would 
be of greatest benefit to recovery, while others 
argue for their positive contributions after an 
injury (Sofroniew and Vinters, 2010).  Even with 
differing opinions on the role of astrocytes after 
SCI, many agree that they should be investigated 




 As mentioned previously, the environment 
surrounding the lesion epicenter at acute time 
points after an SCI has been extensively studied 
(Popovich et al., 1996; Mautes et al., 2000; 
Bareyre and Schwab, 2003).  After an injury, 
through primary damage to vasculature, 
peripheral immune cells are able to enter into the 
previously isolated central nervous system 
(CNS) and greatly impact the spinal cord 
structure and function.  This primary injury leads 
to entrance of neutrophils and T-lymphocytes 
into the injury site.  These cells release cytokines 
that regulate cell-to-cell communication and 
produce multiple cytotoxic effects on 
surrounding tissues.  In the acute phase of the 
secondary injury response, ischemic damage 
(Sandler and Tator, 1976) leads to increases in 
free radicals and excitatory neurotransmitters, 
and the activation of glial cells including 
microglia and astrocytes.   
 
 Microglia become activated and contribute 
to phagocytosis and pro-inflammatory cytokine 
production.  As peripheral immune cells and 
macrophages are recruited into the epicenter, 
they contribute to a secondary wave of 
inflammation.  This continues out to 42 days 
after the injury and can have a negative impact 
on recovery. This can also further damage 
vulnerable tissue around the impact site where 
the initial cell death occurs (Popovich and 
Hickey, 2001; David et al., 2014). 
 
 Activated astrocytes also express pro-
inflammatory cytokines, glial fibrillary acidic 
protein (GFAP), and other markers of activation 
following SCI (Sofroniew and Vinters, 2010). 
Tumor necrosis factor alpha (TNFα) and 
interleukin-1 beta (IL-1β), contribute further to 
damage of tissue and induce the expression of 
intracellular adhesion molecule 1 (ICAM-1), 
which helps with trafficking of peripheral 
immune cells into the CNS. At acute time points 
following a severe contusion, astrocytes at the 
epicenter proliferate demonstrating overlapping 
of astrocytic domains, cell body hypertrophy, 
and glial scarring.  The resulting glial scar serves 
as a physical and chemical barrier around the 
primary lesion to isolate the injury site from the 
rest of the spinal cord tissue.  Activated 
astrocytes also serve to inhibit axon regeneration 
at the epicenter through the production of 
chemicals and cause cytotoxic edema through 
the disregulation of aquaporin water channels 
(Sofroniew and Vinters, 2010; Gwak et al., 
2011).  Over time, damage to channels and 
receptors persist and have been associated with 
the development of chronic neuropathic pain 
(CNP) and sensitivity of dorsal horn neurons 
(Bareyre and Schwab, 2003). As a result, this 
secondary injury response has become a prime 
target for pharmacological therapies (Kwon et 




 Remote from the site of the lesion, in the 
lumbar cord, much less is known. This area is 
important because of its role in locomotor 
functioning, and has started to receive increased 
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scrutiny in the field.  Activation of glial cells 
caudal to the epicenter has also been found to 
contribute to CNP (Detloff et al., 2008; Nesic et 
al., 2005). Our lab has identified activated 
microglia as soon as 24h after injury up to 10 
segments caudal to the injury site (Detloff et al., 
2008; Hansen et al., 2013). In a timecourse 
study, we showed increased expression of TNFα 
and IL1β by 7d that returned to basal levels by 
35d in the dorsal horn of the lumbar cord. 
Interleukin 6 (IL6), also a pro-inflammatory 
cytokine, was found to have increased levels of 
expression at more chronic 21 and 35 days post 
injury (dpi) (Detloff et al., 2008).  
 
 There is conflicting evidence regarding 
whether reactive astrocytes display upregulation 
of GFAP at chronic time points in the lumbar 
cord (Detloff et al, 2008, Nesic et al, 2005).  At 
35d in the L5 dorsal horn, we previously found 
increased GFAP mRNA without a resulting 
increase in GFAP protein levels (Detloff et al., 
2008).  Nesic et al., however, found increased 
expression of GFAP, S100β, and Aquaporin- 4 
(AQP4) that persisted to nine months after injury 
(Nesic et al., 2006).  
 
 Aquaporin water channels have been found 
to be over-expressed after SCI in the dorsal horn 
of the lumbar cord up to 9 months post injury. 
They are thought to be involved in edema and 
disruption of the water/ion homeostatic balance 
after injury (Nesic et al., 2005).  In the brain, 
AQP4 has been implicated in cytotoxic edema, 
since removal of channels led to increased 
edema.  Since these channels are localized to the 
endfeet of the astrocytes, it has also been 
postulated that they have an important role in the 
function of the BBB and BSCB (Francesca and 
Rezzani, 2010). Nesic et al. argued that this 
swelling of the endfeet had a negative impact on 
sensory dysfunction after injury, including 
development of central neuropathic pain.  
Animals that displayed CNP also showed a 
significant increase in AQP4 mRNA expression.  
They hypothesized that these dysfunctional 
astrocytes were releasing excessive amounts of 
the excitatory neurotransmitter glutamate, 
leading to hyperexcitability of neurons in 
spinothalamic pathways. 
 
BBB/BSCB:  	  
 
 The BSCB is composed of capillary 
endothelial cells connected by tight junctions.  
The astrocytic endfeet abut the basal lamina and 
form the glial limitans (Figure 1).  The BSCB 
functions to prevent the circulating blood from 
entering into the isolated environment of the 
CNS.  It maintains this isolated environment by 
preventing the influx of large and/or hydrophilic 
molecules into the CNS, while allowing the 
entrance of small lipid soluble molecules.  
Permeability of the BSCB allows the entrance of 
peripheral immune cells into the parenchyma of 
the spinal cord, contributing to a toxic 
microenvironment that may disrupt functional 
recovery (Hansen et al., 2013).  MMP-9 has also 
been implicated in BSCB dysfunction. Matrix 
metalloproteinases (MMPs) have a variety of 
Figure 1: Depiction of the blood brain barrier 
including astrocytes (GFAP: glial fibrillary 
acidic protein - green), neurons (blue), 
aquaporin water channels (AQP4: Aquaporin 4 
-black), microglia (Iba-1: Ionized Calcium-
binding Adapter Molecule 1- purple), and 










functions in the spinal cord, and can affect 
inflammation and BSCB functioning.  MMP-9 
contributes to the remote inflammatory 
microenvironment by increasing the permeability 
of the BSCB through degradation of the 
endothelial tight junctions. Activated astrocytes 
release MMP-3 by 24 h after injury, which then 
cleaves the pro-inflammatory form of MMP-9, 
leading to activation.  Increased expression of 
MMP-9 has been observed as early as 7dpi and 
remains upregulated at 9 dpi in the lumbar cord 
(Hansen et al., 2013).   
 
 Breakdown of the BSCB could be one 
reason for the extravasation of peripheral 
immune cells into the lumber tissue. It could 
then be contributing to the pro-inflammatory 
microenvironment in this way. Our lab has also 
observed increased expression of pro-
inflammatory TNFα in the lumbar enlargement 
7d after SCI in mice (Hansen et al., 2013).  Our 
lab has also shown BSCB permeability to Evans 
Blue Dye remote to a 9th thoracic segment (T9) 
contusion injury throughout the dorsal and 
intermediate grey matter within lumbosacral 
segments in mice by 7 dpi (Hansen et al., 
unpublished). The presence of remote BSCB 
breakdown and a pro-inflammatory 
microenvironment proved refractive to exercise-
based therapies at early time points after injury, 
when neuroplasticity is postulated to be at its 
highest and is of increasing interest in promoting 
recovery after SCI (Hansen et al., 2013). 
 
 Opening of the BSCB has also been 
reported in uninjured mice in response to 
neuronal activity (Arima et al., 2012).  Following 
electrical stimulation of the soleus muscle, 
Arima noted an inherent leakiness of the BSCB 
at L5 (Lumbar segment 5) where an influx of 
pathogenic CD4+ T cells into the CNS occurred 
via the dorsal blood vessels.  This finding led to 
the belief that L5 is the 'gatekeeper' through 
which autoreactive T cells enter the spinal cord 
in experimental autoimmune encephalomyelitis 
(Arima et al., 2012). Dysfunction and/or opening 
of the BSCB barrier allows one avenue for the 
extravasation of peripheral immune cells into the 
CNS and may contribute to the toxic 
microenvironment observed in the lumbar cord 




 At chronic time points after a moderate 
contusive spinal cord injury, we hypothesize that 
there will be continuous dysfunction in the 
intermediate lumbar grey matter of the spinal 
cord.  Additionally, we hypothesized that 
astrocytes would contribute to disturbances in 
fluid balance and cytotoxic edema through the up 
regulation of AQP4 channels along the endfeet, 
leading to swelling of these processes. Finally, 
we expected that active trafficking of peripheral 
immune cells would be shown through 
upregulation of ICAM1.  Overall, we 
hypothesize that astrocytic dysfunction and 
increased expression of glial cells after thoracic 
injury would in fact be present in the lumbar 
cord. 	   	  	  
 
Materials and Methods 
 
Subjects and Surgeries: 
 
Experiments were conducted in 
accordance with The Ohio State University 
Institutional Laboratory Animal Care and Use 
Committee.  Adult (2 months) female C56BL/6J 
wild-type mice were obtained from the Jackson 
Laboratory.  Mice were housed 3-4 per cage in a 
12h light/dark cycle, and provided with food and 
water ad libitum.  Laminectomy and spinal cord 
contusion injuries were performed as described 
previously (Jakeman et al., 2000; Kigerl et al, 
2006, Hansen 2013).  Briefly, mice were 
anesthetized with a mixture of ketamine (80 
mg/kg) and xylazine (20 mg/kg) injected 
intraperitoneally and given prophylactic 
antibiotics (gentocin, 1 mg/kg) subcutaneously 
(subQ).  Using aseptic techniques, the spinous 
process and lamina of T9 were removed to 
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expose the dura mater (Figure 2B).  The 
vertebral column was stabilized with clamps in 
a stereotactic device at the T8 and T10 vertebral 
bodies and a moderate-severe contusion injury 
was induced by delivering a 75-kilodyne force 
injury using the Infinite Horizon Impactor 
(Precision Systems and Instrumentation, LLC, 
Fairfax Station, VA) (Figure 2A).  The incision 
was closed in layers and 2 cc of sterile saline 
was provided subcutaneously to prevent 
dehydration.  Mice received antibiotics (1 
mg/kg gentocin, subQ) and saline for 5d after 
injury.  Bladders were manually expressed twice 
per day until tissue was harvested (Hoschouer et 
al, 2010). 
 
 Deviations of force and displacement 
were analyzed in order to exclude biomechanical 
outliers of the injury (n=2).  Animals (n=3) were 
also excluded based on health complications 
(ascites, n=1; eye prolapse, n=1; tooth caught in 
surgical staple, n=1).  Open field locomotion was 
assessed at 1 dpi in order to screen for behavioral 
outliers using the Basso Mouse Scale (BMS) for 
Locomotion.  Animals with a BMS score greater 
than 1.5 were removed from the study (n=2). 
Randomized group assignment and blinded BMS 
assessments occurred for all animals.  Animals 
were also excluded from the study following 
tissue collection as some tissue was 




 At previously determined endpoints, each 
animal was sacrificed by cardiac perfusion with 
5 mL phosphate buffer (PB, pH 7.4), followed 
by 10 mL of paraformaldehyde (4%, pH 7.2) 
fixative.  The animal was then perfused with 10 
mL of Tomato Lectin (10ul/ml) to label the 
vasculature and finally 30 mL of 
paraformaldehyde.  The remaining laminae of 
the vertebrae were removed and tissue was 
collected from the epicenter (5 mm on either side 
of the area of impact at T9), as well as the 
lumbar region spanning from L1 to the caudal 
end of the cord.  All tissue was post-fixed in 4% 
paraformaldehyde for 4 hours and then rinsed for 
24 h in 0.2M PB.  Tissue was then cryoprotected 
in 30% sucrose, blocked in Tissue-Tek OCT 
compound (Optimal Cutting Temperature, 
Hatfield, PA) and then transversely sectioned at 
a 20 micrometer (µm) thickness on a Microm 
HM505E cyrostat (Electron Microscopy 
Sciences, Hatfield, PA).  Naïve animals 22 and 
23 were injected with the vascular tracer Evans 
Blue Dye, prior to sacrifice; however this was 
not quantified.      
 
White Matter Sparing:  
 
The lesion site was sectioned transversely 
at 20 um and stained for myelin to determine the 
lesion area and white matter sparing at the injury 
epicenter.  Eriochrome cyanine (EC) staining, 
followed by differentiation with 5% iron alum 
and borax ferricyanide solutions, was performed 
as described previously (Basso et al., 2006; 
Kloos et al., 2005).  The epicenter of the injury 
was determined as the section with the least 
amount of spared white matter and with the 
largest central lesion.  Tissue was analyzed under 
light microscopy and converted to a computer 
image (MCID-Elite, Imaging Research, Ontario).  
A grid was positioned on each section randomly 
using Cavalerri estimator, and each point (p) was 
 
Figure 2A: Stereotactic device to stabilize animals for 
contusion injury 




assigned as white matter, grey matter, or lesion 
(Figure 3).  For each area 
(dorsal/ventral/left/right), the point totals were 
added and converted to area as follows: 
estimated area = (ΣP) * (a/p) (ΣP is the sum of 
the points for an individual section; a/p is the 
area of each point) (Figure 3A).  White matter 
sparing was compared to average LAM white 
matter, and lesion area was calculated compared 
to average section area of LAM controls.  At this 
point, the 35 dpi timepoint was removed from 




 GFAP is an intermediated filament that is 
expressed by astrocytes, and is found to be 
upregulated in reactive astrocytes.  Studies have 
shown that this protein is extremely important in 
the formation of a glial scar and in astrocytic 
reactivity (Sofroniew and Vinters, 2010).  We 
evaluated GFAP expression in the lumbar cord 
from acute to chronic time points with the 
hypothesis that morphological indices of 
reactivity in astrocytes do not extend to chronic 
time points in the lumbar cord. 	  
 
 AQP4, which is found localized to the 
endfeet of astrocytes, is an integral membrane 
water channel protein that allows the conduction 
of water through the cell membrane. By 
examining the expression levels of AQP4 after 
SCI, evidence for continuous dysfunction in the 
astrocytes without the typical morphological 
activation seen early after injury is determined.    	  
 
 Tomato lectin was utilized to visualize the 
vascular endothelium of blood vessels supplying  
 
the cord.  In order to determine if there was 
active trafficking of peripheral immune cells into 
the spinal cord, and whether this co-localized 
with the blood vessels, we also stained for the 
expression of intercellular adhesion molecule 1 
(ICAM1).  ICAM-1 is expressed on the inner 
surface of endothelial cells and can be induced 
by TNF-α, IL-1β, along with other products of 
reactive glial cells.  ICAM-1 is also is involved 
in inflammation and T-cell mediated defenses 
(van de Stolpe and van der Saag. 1996).  
 
 The microglia/macrophage response was 
analyzed via staining for ionized	  calcium-­‐
binding	  adapter	  molecule-­‐1	  (Iba-­‐1).	  	  Iba-­‐1	  is	  
expressed	  on	  microglia	  and	  macrophages	  and	  
was	  analyzed	  to	  determine	  





Figure 3: Grid analysis of white matter sparing 






Fluorescent immunohistochemistry was 
performed to examine astrocytes, 
microglia/macrophage reactivity and 
morphology, monocyte trafficking, and AQP4 
channel expression.  To investigate astrocytes a 
1:7500 dilution of rabbit anti-GFAP antibody 
was utilized (Abcam ab7260).  The antibody was 
incubated in blocking solution consisting of 
4%BSA/0.1% Tx-100 in PBS overnight at room 
temperature.  A goat-anti rabbit secondary which 
fluoresces at 488 nm was used at a dilution of 
1:1000 in 4%BSA, 0.1% Tx-100 in PBS 
(AlexaFlour 488, ab150077).  
Microglia/macrophages were examined using a 
1:200 dilution for rabbit anti Iba-1 prepared in 
blocking solution of 1%BSA/0.1%FG/3% 
NGS/0.2% Tx-100 in PBS.  Incubation of the 
primary antibody occurred overnight at 4 degrees 
Celsius (Wako 019-19741).  Iba-1 labeling was 
visualized with a goat anti-rabbit secondary at a 
1:400 dilution (AlexaFlour 488, ab150077).  The 
interface between vasculature and astrocytic end 
feet was visualized by staining for Aquaporin-4 
water channels.  A rabbit anti-AQP4 primary 
antibody was diluted at a concentration of 
1:1000 in 10%NGS/0.3% Tx-100 and PBS 
(Chemicon AB3594).  Slides were incubated in 
the primary overnight at room temperature.  A 
goat anti-rabbit secondary was then used to 
visualize these water channels at a concentration 
of 1:200 in 10%NGS/0.3% Tx-100 and PBS 
(AlexaFlour 488, ab150077).  ICAM-1 labeling 
was achieved by utilizing a goat anti-ICAM1 
primary antibody at a concentration of 1:250 in 
blocking solution consisting of 1%BSA/3% NDS 
in PBS.  The sections were incubated in the 
primary antibody overnight at 4 degrees Celsius 
(R&D Systems, AF796).  ICAM-1 was then 
visualized with a donkey anti-goat secondary at a 
dilution of 1:250, which was incubated overnight 
at 4 degrees Celsius (Abcam 488, ab96935).  For 
all stains, control sections incubated with 
primary and no secondary, and secondary and no 
primary were maintained in order to ensure 
positive labeling. All images were acquired 
using a Zeiss Laser Confocal Microscope (The 
Ohio State University Confocal Microscopy 
Imaging Facility).  Images were taken at 
magnifications of 10x, 20x oil, 60x oil, and 120x 
oil.  
 
Proportional Area Analysis: 
 
Proportional area analysis was performed 
in lumbar cord sections in the intermediate zone 
of the grey matter stained for GFAP, ICAM1, 
Iba-1, and AQP4 (Figure 4A).  The percent 
positive area was determined using ImageJ 
software (http://rsb.info.nih.gov/ij/) on confocal 
images.  The starting point for the proportional 
area analysis was determined as the area above 
the central canal where the medial dorsal horn 
starts to ascend.  A box was then created by 
extending laterally to the border between the 
grey and white matter, and then taken ventrally 
until it reached the medial border between the 
grey and whiter matter below the central canal 
(Figure 4).  One intermediate box size was 





Figure 4: Example of box size 




Microglia Cell Body Size Measurements: 
 
Microglia reactivity was determined by 
measurement of cell body size. Ten cell bodies 
per animal were assessed in the intermediate 
grey matter by systematically progressing 
through the image in a six-section grid to choose 
a representative sample of cell bodies to evaluate 
in the area of interest (Neurolucida). Cell body 
length and width were measured and multiplied 
to acquire average cell body area. 
 
Locomotor assessments:  
 
BMS scores in an open field were 
assessed to determine the extent of recovery after 
injury.  Scores between 0 (no hindlimb 
movement) and 9 (normal locomotor function) 
were attributed to each animal after a four 
minute examination by two raters blinded to 
group assignment.  Assessors determined 
movement of joints, weight-supported steps as 
well as plantar steps, trunk stability, and control 
of tail (Basso et al., 2006).  Assessments were 
obtained at timepoints prior to the injury, 1dpi, 




White matter sparing, proportional area 
measurements, and microglia cell body size was 
analyzed using a One-way ANOVA with Tukeys 
post-hoc analysis. BMS scores were analyzed 
with repeated measures ANOVA with Tukeys 






BMS scores for all SCI timepoints 
showed a consistent response of injury and 
functional recovery among all timepoints 
compared to LAM controls (Figure 5A).  
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Animals showed an initial decrease in function 
indicating either no movement (0) or slight ankle 
movement (1) at 1 dpi.  All SCI groups then 
showed a consistent functional recovery that did 
not differ significantly though 7 days after injury 
(7d = 4.5+/-0.5; 14d = 3.67+/-0.33; 21d = 5+/-0; 
35d = 5+/-0.58; 42d = 2.5+/-0.61).  Longer 
surviving SCI groups also plateaued at a similar 
BMS score by the time of sacrifice (average of 5-
6 - indicates plantar stepping with no 
coordination (5) to some coordination (6)). 
 
Astrocytes displayed increased expression in the 
intermediate grey matter at 7 dpi that continued 
at slightly increased levels through 42 dpi: 
Figure 6A: Confocal images taken at various 
magnifications (20x, 60x, 120x) displaying 
upregulation of GFAP (green) and also labeled 
with tomato lectin (red), and DAPI (blue).  
Figure 6B: Quantification of GFAP proportional 
area with significant upregulation seen at 7 dpi (* 
p < 0.05) that remained slightly increased out to 42 
days after injury. 






Measurements of percent white matter 
sparing also confirmed a similar lesion severity 
between SCI timepoints.  Average WMS ranged 
from 14-21% (7, 14, and 21d timepoints).  SCI 
groups showed significantly less sparing 
compared to LAM controls.  However, these 
were not different from each other, ensuring a 
moderate/severe injury across all SCI groups 
Microglia/macrophages displayed upregulation and a reactive phenotype: 
Figure 7A: Panel displaying Confocal imaging of microglia/macrophages stained with Iba-1 (green), 
tomato lectin (red), and DAPI (blue).   
Figure 7B: Quantification of PA measurements of Iba-1 showing a biphasic increase in expression 
with peaks at 7 and 21 dpi.  
Figure 7C: Quantification of microglia/macrophage cell body size from 60x images showed a 
biphasic response and remained significantly upregulated at 42 dpi.  
(*** p  < 0.001; ** p < 0.01; * p < 0.05; ^^ p < 0.01) 





(One-Way ANOVA with Tukey’s post hoc 
analysis, p < 0.05; LAM = 100% +/- 7.55; 7d = 
14.30 +/- 1.55; 14d = 21.92 +/- 3.29; 21d = 20.16 




To determine the time course of astrocyte 
reactivity in the intermediate grey matter of the 
lumbar cord, proportional area analysis was 
assessed for GFAP (Figure 6A: top panel).  
Astrocytes at 7 dpi displayed a significantly 
increased expression of GFAP (LAM = 0.45 +/- 
0.18; 7d = 4.58 +/- 1.26, p < 0.05).  GFAP 
remained slightly upregulated through 42 dpi 
compared to LAM controls, however it was not 
significant (ranged from 1.81% at 14 dpi to 
2.66% at 42 dpi) (Figure 6B).  Astrocytic 
processes were visualized and displayed 
increased staining of processes (Green) and close 
localization with the vasculature (Red) (Figure 




Microglia/macrophage	  reactivity	  was	  
assessed	  via	  quantification	  of	  Iba-­‐1	  
proportional	  area	  analysis	  in	  the	  intermediate	  
ICAM-1 displayed increased expression at 14 dpi that returned to baseline by 21 dpi 
Figure 8A: Confocal imaging of ICAM-1 (green) expression that seemed to display a slight 
increase at 14 dpi. 
Figure 8B: Quantification of ICAM-1 expression in the intermediate grey matter with highest 
upregulation at 14d (not significant). 
Figure 8C: 20x magnification confocal images showing co-labeling of ICAM-1 and Tomato Lectin 







grey	  matter	  (Figure	  7A).	  	  	  A	  biphasic	  response	  
with	  peaks	  at	  7	  dpi	  and	  21	  dpi	  was	  observed 
which	  remained	  upregulated	  at	  42	  dpi.	  	  
Interestingly,	  there	  was	  a	  decrease	  in	  Iba-1 
expression from 7 to 14 dpi that was not back to 
LAM control levels ((LAM	  =	  1.73	  +/-­‐	  0.20;	  7d	  =	  
9.49	  +/-­‐	  0.70;	  21d	  =	  9.35	  +/-­‐	  1.34;	  p	  <	  0.000;	  
14d	  =	  5.96 +/- 0.75; p < 0.05; 42d	  =	  6.72	  +/-­‐	  
0.99;	  p	  <	  0.01). (Figure 7B).   
 
Evaluation of microglia/macrophage 
activation was assessed via quantification of cell 
body area, and also demonstrated a biphasic 
response.  Cell body size was observed to 
increase significantly at 7 and 21 dpi that 
continued at 42 dpi compared to LAM controls  
(LAM – 3.36 µm2 +/- 0.16; 7d - 6.39 µm2 +/- 
0.31; 21d - 6.58 µm2 +/- 0.61; p < 0.000; 42d - 
5.60 µm2 +/- 0.20; p < 0.001).  Cell body size at 
14 dpi was significantly decreased to control 
levels and was once again increased at 21 dpi 
(14d – 4.52 +/- 0.10; p < 0.01 (compared to 7d); 






Evaluation of active trafficking of 
peripheral immune cells into the lumbar 
microenvironment of the central nervous system 
was observed to increase slightly at 14 dpi  
(7.82% +/- 4.09, p = 0.13) but returned to 
baseline by 21 dpi through 42 dpi (Figure 8B) 
(No significance).  Co-labeling of ICAM-1 and 
tomato lectin was observed indicating 
localization of this cell adhesion molecule to the 




Confocal images taken in the 
intermediate grey matter of the lumbar cord 
(Figure 9) show increased	  co-­‐labeling	  of	  the	  
vasculature	  with	  AQP4	  early.	  This	  co-­‐
localization	  appeared	  to	  be	  slightly	  elevated	  at	  
7	  days	  after	  injury.	  	  From	  14	  through	  21	  dpi,	  
this	  co-­‐labeling	  along	  the	  blood	  vessels	  
showed	  slightly	  less	  staining	  of	  aquaporin	  
channels	  along	  the	  vasculature.	  	  	   
 
Aquaporin is seen to co-label with the vasculature 
Figure 9: Increased co-labeling between blood vessels (red) and aquaporin water channels (green) was 







Increased expression of astrocytes and 
microglia/macrophage markers indicates a 
contribution of these glial cells after a spinal 
cord injury in the lumbar intermediate grey 
matter.  The biphasic response seen in regards to 
microglia/macrophage expression and reactivity 
may indicate a secondary wave of inflammation 
being trafficked into the cord.  These reactive 
glial cells can secrete pro-inflammatory 
cytokines that inhibit synaptic plasticity and 
learning, proving refractive to activity-based 
therapies (Hansen et al., 2013).  Our lab has 
previously shown activation of microglia via 
assessments of cell body size and process 
retraction, along with increased expression of 
pro-inflammatory cytokines (Hansen et al., 2013; 
Detloff et al., 2008)     
 
Our lab has previously shown that 
combination of behavioral treadmill training 
therapies with lessening of inflammatory 
activation through MMP-9 knockout mice 
increases functional recovery (Hansen et al., 
2013).  Task-specific treadmill training is 
capable of harnessing plasticity in locomotor 
networks to promote functional recovery, but 
this effect is dramatically reduced in the presence 
of a pro-inflammatory microenvironment.  When 
plasticity is at its highest, in the early period after 
an injury, treadmill focused training can have a 
detrimental impact on return-of-function, 
theorized to be caused by an environment that 
proves refractive to these therapies (Hansen et 
al., 2013). We have shown, through knockout of 
MMP-9, that levels of TNFα remained reduced 
over the first week after injury that returned to 
baseline by 7 dpi.  MMP-9 knock out animals 
had a more robust response to behavioral 
treadmill training as well.  Microglia activation 
was also shown to be reduced at 7 dpi compared 
to wild type animals (Hansen et al., 2013).  The 
production of pro-inflammatory cytokines by 
reactive glial cells in areas important for 
locomotor function, including CPG networks, 
can potentially impact efficacy of treadmill 
training therapies. 
 
 Comparison of BMS scores and the 
percent white matter sparing until animal 
sacrifice ensured a similar lesion severity across 
all SCI groups.  At 1 dpi, the animals showed 
only slight ankle movements on average, 
indicating a similar severity of damage.  As time 
passed, and spinal shock resolved, all groups 
showed a similar path of recovery that plateaued 
at the same level between groups.  By the time of 
sacrifice, all animals showed on average plantar 
stepping without coordination, displaying a 
similar recover across groups and a similarity 
between injuries with no significance between 
groups (Basso et al., 2006).  WMS between SCI 
groups was not significantly different, except 
when compared to LAM controls, further 
ensuring lesion severity and similarity.   
   
Astrocytes exhibited significantly greater 
expression of GFAP at the 7-day timepoint that 
was reduced by 14 dpi which could indicate 
reduced activation in the lumbar cord at chronic 
timepoints.  This up-regulation could be 
attributed to increased staining of processes, 
proliferation of astrocytes in the lumbar 
intermediate grey matter, or increased 
recruitment of reactive astrocytes into the 
environment caudal from the lesion.  Confocal 
imaging seemed to support increased staining of 
astrocytic processes in the injured tissue, but 
more quantification of this must be performed in 
order to confirm.  This upregulation of GFAP 
indicates that astrocytes are being affected at 
locations well away from the lesion site, and 
could be contributing to toxicity in the 
parenchyma of the spinal cord, and preventing 
plasticity and recovery.  Pro-inflammatory 
cytokines like TNFα or IL-1β are produced in 
part by reactive astrocytes, and can prevent 
improvement in recovery from CPG - targeted 
therapies.  Cell cycle proteins can activate 
astrocytes and it has been shown that using a 
cyclin-dependent kinase inhibitor can prevent the 
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activation of glial cells after injury, as well as the 
release of TNFα and IL-1β (Gwak et al., 2012).  
This shows that targeting TNFα and IL-1β, 
which can negatively impact locomotor recovery 
could increase the advantage of these 
behaviorally focused treatments.   
  
Reactive astrocytes produce MMP-3, 
which breaks down collagen type IV, an 
essential component to maintenance of the 
integrity of the basil lamina of the BBB (Guertin, 
2012).  As astrocytes displayed the highest 
expression of GFAP at 7 days after injury, they 
could then be causing increased expression of 
ICAM-1 at 14 days after injury, as the MMP-3 
helps to break down collagen type IV in the basil 
lamina. MMP-3 also cleaves the pro-
inflammatory form of MMP-9, which is 
implicated in degrading the tight junctions 
between endothelial cells of the BSCB (Hansen 
et al., 2013).  This process can be further 
elucidated by examining BSCB permeability 
after SCI in the lumber cord out to and past 14 
dpi, to see if the potential for peripheral immune 
cells to enter the lumber parenchyma and 
contribute to aberrant plasticity is possible.  
Evaluating MMP-3 and MMP-9, as well as 
occludin, a tight junction marker between 
endothelial cells, and collagen type IV, could 
give us a better understanding of the role of 
astrocytes and microglia in breakdown of the 
BSCB, that then allows the entrance of 
peripheral cells into the isolated spinal cord that 
adds to an environment that does not respond 
well to activity based interventions. 
 
The role of aquaporin water channels in 
disturbances of edema and the environment of 
the intermediate grey matter showed some 
increased co-labeling with tomato lectin early 
after injury in the lumbar cord, as well as 
decreased co-localization at later timepoints (14-
21 dpi). The lack of AQP4 expression at the 
interface between the vessels and astrocytes at 
later timepoints could be attributed to 
proliferation of new processes or astrocytes that 
lack these water channels (Nesic et al., 2010).  
Further examination of aquaporin channels, and 
whether there is evidence of water dysregulation 
could provide greater insight into the role of 
astrocytes in dysfunction in the spinal cord.  
Quantification of the presence or absence of 
these channels localized to the blood vessels is 
needed to elucidate this role.   
 
As microglia are the immune surveyors 
of the nervous system, they react quickly to an 
insult by retraction of their processes and 
hypertrophy of their cell bodies (Gwak et al., 
2012).  Iba-1 is a marker of microglia, as well as 
peripheral macrophages that are recruited into 
the nervous system.  Microglia/macrophages 
were found to display a biphasic upregulation in 
Iba-1 from 7 through 42 dpi, with peak 
expression at 7 and 21 days after injury.  This 
same response was seen when phenotype was 
evaluated, by determining the average cell body 
size at each timepoint.  The biphasic response we 
observed may indicate a secondary wave of 
inflammation being trafficked into the lumbar 
parenchyma, and could be a potential target to 
reduce the toxicity associated with the products 
of these immune cells.  Initially, microglia are 
activated soon after the injury and produce 
multiple cytokines and other chemicals that can 
then lead to recruitment of peripheral immune 
cells into the cord secondarily.  By preventing 
this subsequent wave of inflammation, 
behavioral therapies may better harness the 
endogenous plasticity present in the cord without 
hindrance from a toxic microenvironment.  
 
Further confirmation of microglial 
activation and pro-inflammatory cytokine 
production must be done. Previously, in the 
dorsal horn of the lumbar, our lab saw 
upregulation and reactivity of microglia out to 35 
dpi and hypothesized their correlation with 
chronic neuropathic pain (Detloff et al., 2008).  
In the intermediate grey matter, reactive 
microglia/macrophages could be contributing to 
the development of spasticity after injury, in 
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which there is aberrant signaling from the alpha 
motor neuron that does not have any regulatory 
control from the upper motor neuron.  More 
about their part in contributing to toxicity that 
prevents functional recovery must be elucidated, 
by determining whether these reactive 
microglia/macrophages are secreted 
inflammatory cytokines that could contribute to a 
noxious environment.  Investigations of the 
presence of TNFα, IL-1β, MMPs, and other 
secretory factors of microglia, will be the next 
step to determine the effect they might have in 
this essential area of the spinal cord after an 
injury. 
 
Trafficking of peripheral immune cells 
into the isolated environment of the CNS was 
evaluated using ICAM-1, and the highest 
proportional area was found at the 14 dpi 
timepoint.  Although this was not significant, it 
showed an interesting relationship with the 
microglia and astrocyte response, as the highest 
percent proportional area for ICAM-1 was seen 
with the lowest microglial expression, and 
decreased reactivity as evaluated by a decrease in 
cell body size compared to 7 and 21-day SCI 
groups.   
	  
	   Additionally,	  using other markers of 
astrocytes, including S100β or glutamine 
synthetase, may be able to enhance the study of 
astrocytes following SCI.  GFAP stains an 
intermediate filament present in astrocytes, but 
may not provide a full picture of astrocytic 
reactivity.  Determination of whether astrocytes 
are proliferating or if there is increased staining 
of finely branching processes and the extent of 
this branching and the cell bodies are not 
determinable through GFAP staining, and can 
lead to underestimation of astrocytic presence 




In conclusion, we discovered activation 
of glial cells in locomotor regions of the lumbar 
spinal cord involved in CPG functioning and in 
interneuronal communication within the 
intermediate grey matter that continued at some 
level through chronic timepoints.  Based on our 
previous findings, it is likely that these reactive 
microglia/macrophages and astrocytes are 
contributing to a toxic microenvironment 
through the production of inflammatory 
cytokines and products that serve to breakdown 
the BSCB, thus allowing trafficking of 
peripheral cells in the spinal cord.  This 
secondary inflammatory response in the lumbar 
microenvironment proves refractive to activity-
based therapies and prevents functional recovery 
after an injury.  The biphasic response seen with 
staining of Iba-1 and increased 
microglia/macrophage cell body size may 
indicate a secondary wave of inflammation, 
potentially being trafficked in from the periphery 
that negatively impacts plasticity in the cord.  
Further investigation into the role of these 
products of reactive glial cells, and their role in 
breakdown of the BSCB, may provide a 
therapeutic target for improving outcomes using 
behavioral treatments.  More information and 
quantification of the role of aquaporin water 
channels in this toxic microenvironment could 
further elucidate their role in dysfunction as well.  
Overall, astrocytes and microglia displayed 
upregulation of markers indicating reactivity. 
Further study of how they are contributing to 
toxicity in the lumber parenchyma may allow 
locomotor therapies to harness the natural 
plasticity present after an injury, improving 
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